Evaluation of Patients With Liver Disease
|ClinicalTrials.gov Identifier: NCT00001971|
Recruitment Status : Recruiting
First Posted : January 19, 2000
Last Update Posted : December 6, 2017
The proposed study aims to evaluate, investigate, and follow-up patients suffering from acute and chronic liver disease. The study will focus on understanding diseases affecting the liver.
Patients participating in the study will first undergo a routine check-up as an outpatient. They will be asked to provide blood and urine samples for laboratory testing and will undergo an ultrasound of the liver. Ultrasound examinations use sound waves to determine the size and texture of the liver. After the initial visit subjects will be requested to follow-up once a year at the outpatient department for a similar check-up.
Additional tests may be requested throughout the study to provide information for other research studies and individual consent will be requested. These tests may include liver biopsies, skin biopsies, and / or specialized blood, plasma, and lymphocyte examinations.
Subjects that qualify for medications presently being studied may be offered the opportunity to benefit from experimental therapy.
|Condition or disease|
|Biliary Liver Cirrhosis Hemochromatosis Hepatitis Hepatolenticular Degeneration Liver Disease|
|Study Type :||Observational|
|Estimated Enrollment :||99999999 participants|
|Official Title:||Evaluation of Patients With Liver Disease|
|Study Start Date :||September 10, 1991|
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00001971
|Contact: Amy (Wen-Chun) Huang||(301) firstname.lastname@example.org|
|Contact: T. Jake Liang, M.D.||(301) email@example.com|
|United States, Maryland|
|National Institutes of Health Clinical Center, 9000 Rockville Pike||Recruiting|
|Bethesda, Maryland, United States, 20892|
|Contact: For more information at the NIH Clinical Center contact Patient Recruitment and Public Liaison Office (PRPL) 800-411-1222 ext TTY8664111010 firstname.lastname@example.org|
|Principal Investigator:||T. Jake Liang, M.D.||National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|